β¨ Health and Internal Affairs Notices
NEW ZEALAND GAZETTE
No. 122
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Cefixime 100 mg per 5 ml | Powder for oral suspension | Biocraft Laboratories Inc., New Jersey, U.S.A. | |
| Nizatidine 300 mg | Capsule | Eli Lilly & Company, Indiana, U.S.A. | Axid |
| Nizatidine 50 mg and 100 mg | Vial for injection | Eli Lilly & Company, Indiana, U.S.A. | |
| Celiprolol hydrochloride 200 ml | Tablet | Rorer Pharmaceuticals, U.K. and Eire | Selectol |
| Cephalexin 250 mg and 500 mg | Capsule | Glaxo Operations U.K. Ltd., England | Ceporex |
| Cephalexin 125 mg per 5 ml | Granules for oral suspension | Glaxo Operations U.K. Ltd., England | Ceporex |
| Cephalexin 250 mg per 5 ml | Granules for oral suspension | Glaxo Operations U.K. Ltd., England | |
| Mequitazine 5 mg | Tablet | May & Baker Ltd., England | Primalan |
| Tranexamic acid 500 mg | Tablet | KabiVitrum, Sweden | Cyklokapron |
| Tranexamic acid 100 mg/ml | Solution | KabiVitrum, Sweden | Cyklokapron |
| Verapamil HCl 40 mg, 80 mg, 120 mg | Tablet | Glaxo New Zealand Ltd. | Verapamil |
| Hydrocortisone-17-butyrate 0.1% w/w | Cream, ointment, lotion | Glaxo New Zealand Ltd. | Hydrocortisone Butyrate Cream, Ointment, Scalp Lotion |
| Polyoxyl 40 stearate and Polyethylene glycol 300 | Solution | Holopack Verpackungstechnik GmbH, West Germany | Lens Fresh |
| Frusemide 40 mg | Tablet | Rorer Pharmaceuticals Co. Ltd., U.K. and Italy | Frumil |
| Amiloride 5 mg (as the hydrochloride) | Tablet | ||
| Tenoxicam 20 mg | Vial and ampoule for injection | F. Hoffmann-La Roche & Co. Ltd., Switzerland | Tilcotil |
Dated this 4th day of July 1988.
JONATHAN HUNT, for DAVID CAYGILL, Minister of Health.
GS7318
Consent to Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| 5% w/w each of camphor, menthol and phenol | Lotion | Stiefel Laboratories (U.K.) Ltd. | Sama Lotion |
Dated this 5th day of July 1988.
JONATHAN HUNT, for DAVID CAYGILL, Minister of Health.
GS7316
Internal Affairs
Tauranga Harbour Bridge Bylaw 1988
Bylaws Act 1910
Tauranga City Council Bylaw Confirmed
The following certificate has been executed on a sealed copy of the Tauranga Harbour Bridge Bylaw 1988 made by special order by the Tauranga City Council on 9 February 1988 and confirmed at a subsequent meeting held on 7 March 1988.
Signed at Wellington this 30th day of June 1988.
MICHAEL BASSETT, Minister of Local Government.
Certificate of Confirmation
Pursuant to the Bylaws Act 1910, I hereby confirm the above written bylaw and declare that the same came into force on 14 March 1988.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1988, No 122
NZLII —
NZ Gazette 1988, No 122
β¨ LLM interpretation of page content
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare4 July 1988
Medicines Act 1981, New Medicines, Distribution, Consent
- JONATHAN HUNT, for DAVID CAYGILL, Minister of Health
π₯ Consent to Distribution of a New Related Product
π₯ Health & Social Welfare5 July 1988
Medicines Act 1981, New Related Product, Distribution, Consent
- JONATHAN HUNT, for DAVID CAYGILL, Minister of Health
ποΈ Tauranga Harbour Bridge Bylaw 1988 Confirmed
ποΈ Provincial & Local Government30 June 1988
Bylaws Act 1910, Tauranga Harbour Bridge Bylaw, Confirmation
- MICHAEL BASSETT, Minister of Local Government